^
Association details:
| Biomarker: | PD-L1 overexpression |
|---|---|
| Cancer: | Lung Cancer |
| Drug: | EPIM-001 (PD-L1 inhibitor, IL-2Rβ partial agonist) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
LB214 / 5 - Discovery of EPIM-001, a tumor targeted engineered IL2 with biased IL2Rß agonist activities
Published date:
03/09/2022
Excerpt:
...EPIM-001 has shown significant tumor growth inhibition against the human lung cancer cell line H1975, which whilst expressing high levels of PD-L1...
